Finally, T2D patients showed increased serum sclerostin levels compared to non-diabetic individuals (53.61 ± 24.96 vs 41.99 ± 16.60 pmol/L, p = 0.0032). The gene discussed is SOST; the disease is type 2 diabetes mellitus.